SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004066
Filing Date
2024-01-29
Accepted
2024-01-29 08:30:40
Documents
16
Period of Report
2024-01-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47538
2 ex99-1.htm EX-99.1 22529
3 ex99-1_001.jpg GRAPHIC 91161
  Complete submission text file 0001493152-24-004066.txt   377256

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pali-20240129.xsd EX-101.SCH 3024
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pali-20240129_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pali-20240129_pre.xml EX-101.PRE 22365
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3662
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 24570530
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)